Fosun's Core Businesses Stay Firm Despite One-off Non-cash Loss
On 30 March, Fosun International (00656) announced its 2024 annual results, reporting a total revenue of RMB192.14 billion. The Group's four core subsidiaries – Yuyuan, Fosun Pharma, Fosun Insurance Portugal, and Fosun Tourism Group ("FTG") – generated a total revenue of RMB134.65 billion, accounting for 70.1% of the Group's total revenue. The loss attributable to […]